Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About MedInvestNews
BioSig Technologies
Biotech Insights
Biotech News
Cannabis & CBD
CEO Interviews
Citius Pharmaceuticals
Content & Advertising
Drug Manufacturers
Funds & Investment Banks
Hemispherx BioPharma
Immunotherapy & Biotech
iPhone
Latest Interviews
Medical Cannabis
Medical Equipment & Supplies
Mining Stocks
Mobile Apps & SaaS
Nano Dimension
Origin Clear
Pacific Green Technologies
Past Roadshows
Payements & Blockchain
Saas & Mobile
Services
Stock Geeks
Surge Holdings
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BiotechStocktrader
-
April 2, 2019
0
Hemispherx (NYSE:HEB) Starting Two New Clinical Trials at Major US Cancer Centers
BiotechStocktrader
-
January 16, 2019
0
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
BiotechStocktrader
-
April 30, 2019
0
CEO Interviews
Home
CEO Interviews
Featured posts
CEO Interviews
Citius Pharma (CTXR) Chairman, Leonard Mazur Discusses Progress and Timeline for...
BiotechStocktrader
-
December 11, 2018
0
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug...
BiotechStocktrader
-
December 14, 2018
0
CEO Interviews
BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market
BiotechStocktrader
-
October 20, 2018
0
CEO Interviews
Hemispherx Biopharma (HEB) CEO Discusses Progress in Immunotherapy & Pancreatic Cancer...
BiotechStocktrader
-
March 21, 2019
0
1
2
3
Page 1 of 3
- Advertisement -
LATEST NEWS
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002
BiotechStocktrader
-
May 8, 2020
ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference
BiotechStocktrader
-
May 8, 2020
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3...
BiotechStocktrader
-
May 8, 2020
Hemispherx Biopharma Announces Significant Progress in its Ampligen Ovarian Cancer Program
BiotechStocktrader
-
May 1, 2019
LATEST INTERVIEWS
Precision Therapeutics (AIPT) Bringing AI to Precision Medicine
BiotechStocktrader
-
December 4, 2018
0
Latest Interviews
In this episode of CEOLIVE.TV we are joined by Richard Gabriel, COO of TumorGenesis, a wholly owned subsidiary of Precision Therapeutics, ticker AIPT. About Precision...
381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832
Edit with Live CSS
